Laboratory biomarkers for multiple sclerosis and their role in clinical practice
Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) most commonly diagnosed in young adults. In recent decades, new treatments have emerged that have radically changed the prognosis and quality of life of these patients. However, this has also raised new challenges in p...
Saved in:
Main Authors: | I. Navickaitë, G. Žemgulytė, R. Balnytė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2023-11-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33564 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated Kappa Index in the Absence of Cerebrospinal Fluid IgG Oligoclonal Bands: Contribution of Intrathecal IgM and IgA Synthesis
by: Krzysztof Smolik, et al.
Published: (2025-01-01) -
No Relation Between Cognitive Impairment, Physical Disability and Serum Biomarkers in a Cohort of Progressive Multiple Sclerosis Patients
by: Bartosz Gajewski, et al.
Published: (2025-01-01) -
Optic neuritis and multiple sclerosis association
by: L. Matukynaitė, et al.
Published: (2020-09-01) -
Clinical Characteristics of Early-Onset and Late-Onset Multiple Sclerosis in Patients from Lithuania
by: Emilija Šlajūtė, et al.
Published: (2025-01-01) -
Intrathecal Immunoglobulin A Synthesis in Multiple Sclerosis: From Biological Aspects to Clinical Relevance
by: Dariia Kliushnikova, et al.
Published: (2025-01-01)